Akebia Therapeutics (AKBA) Q1 2026 Earnings

26FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.05
-0.02
0
0.03

Details

Expected EPS
-0.036
Actual EPS
-0.05
Surprise EPS
-0.01
Surprise Percent
+38.89%

Description

Akebia Therapeutics (AKBA) has reported earnings of -0.05 per share for Q1 2026.

0 Comments

Share your thoughts